back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-03-14 17:01 Tx date 2023-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
350,000 | |
| Filed 2022-03-14 17:08 Tx date 2022-03-10 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
260,000 | |
| Filed 2021-12-07 16:32 Tx date 2021-12-06 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$97,600
+4,000 vol $24.40 each |
4,000 | |
| Filed 2021-12-07 16:22 Tx date 2020-08-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 17:10 Tx date 2021-03-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
160,000 | |
| Filed 2020-08-17 19:39 Tx date 2020-08-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2020-08-17 19:35 Tx date 2020-08-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Von Seggern, Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|